Literature DB >> 36173104

Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses.

Morgane Mitermite1, Dylan Gerard Ryan2,3, Mimmi L E Lundahl4,5, Sarah Case6, Niamh C Williams2, Ming Yang3, Roisin I Lynch4, Eimear Lagan7, Filipa M Lebre4, Aoife L Gorman4, Bojan Stojkovic1, Adrian P Bracken7, Christian Frezza3, Frederick J Sheedy6, Eoin M Scanlan5, Luke A J O'Neill2, Stephen V Gordon1, Ed C Lavelle4.   

Abstract

Macrophages are a highly adaptive population of innate immune cells. Polarization with IFNγ and LPS into the 'classically activated' M1 macrophage enhances pro-inflammatory and microbicidal responses, important for eradicating bacteria such as Mycobacterium tuberculosis. By contrast, 'alternatively activated' M2 macrophages, polarized with IL-4, oppose bactericidal mechanisms and allow mycobacterial growth. These activation states are accompanied by distinct metabolic profiles, where M1 macrophages favor near exclusive use of glycolysis, whereas M2 macrophages up-regulate oxidative phosphorylation (OXPHOS). Here, we demonstrate that activation with IL-4 and IL-13 counterintuitively induces protective innate memory against mycobacterial challenge. In human and murine models, prior activation with IL-4/13 enhances pro-inflammatory cytokine secretion in response to a secondary stimulation with mycobacterial ligands. In our murine model, enhanced killing capacity is also demonstrated. Despite this switch in phenotype, IL-4/13 trained murine macrophages do not demonstrate M1-typical metabolism, instead retaining heightened use of OXPHOS. Moreover, inhibition of OXPHOS with oligomycin, 2-deoxy glucose or BPTES all impeded heightened pro-inflammatory cytokine responses from IL-4/13 trained macrophages. Lastly, this work identifies that IL-10 attenuates protective IL-4/13 training, impeding pro-inflammatory and bactericidal mechanisms. In summary, this work provides new and unexpected insight into alternative macrophage activation states in the context of mycobacterial infection.
© 2022, Lundahl et al.

Entities:  

Keywords:  cytokine; immunology; immunometabolism; inflammation; innate immunity; macrophages; mouse; mycobacterium tuberculosis

Mesh:

Substances:

Year:  2022        PMID: 36173104      PMCID: PMC9555863          DOI: 10.7554/eLife.74690

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  68 in total

Review 1.  Macrophage heterogeneity and plasticity in tuberculosis.

Authors:  Arshad Khan; Vipul Kumar Singh; Robert L Hunter; Chinnaswamy Jagannath
Journal:  J Leukoc Biol       Date:  2019-04-02       Impact factor: 4.962

2.  Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages.

Authors:  Eva M Palsson-McDermott; Anne M Curtis; Gautam Goel; Mario A R Lauterbach; Frederick J Sheedy; Laura E Gleeson; Mirjam W M van den Bosch; Susan R Quinn; Raquel Domingo-Fernandez; Daniel G W Johnston; Jian-Kang Jiang; Jain-Kang Jiang; William J Israelsen; Joseph Keane; Craig Thomas; Clary Clish; Matthew Vander Heiden; Matthew Vanden Heiden; Ramnik J Xavier; Luke A J O'Neill
Journal:  Cell Metab       Date:  2015-01-06       Impact factor: 27.287

Review 3.  First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses.

Authors:  Tom H M Ottenhoff; T Mark Doherty; Jaap T van Dissel; Peter Bang; Karen Lingnau; Ingrid Kromann; Peter Andersen
Journal:  Hum Vaccin       Date:  2010-12-01

4.  Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21.

Authors:  Emer E Hackett; Hugo Charles-Messance; Seónadh M O'Leary; Laura E Gleeson; Natalia Muñoz-Wolf; Sarah Case; Anna Wedderburn; Daniel G W Johnston; Michelle A Williams; Alicia Smyth; Mireille Ouimet; Kathryn J Moore; Ed C Lavelle; Sinéad C Corr; Stephen V Gordon; Joseph Keane; Frederick J Sheedy
Journal:  Cell Rep       Date:  2020-01-07       Impact factor: 9.423

Review 5.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

Review 6.  Lectin Receptors Expressed on Myeloid Cells.

Authors:  Gordon D Brown; Paul R Crocker
Journal:  Microbiol Spectr       Date:  2016-10

7.  Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway.

Authors:  Julius A Potian; Wasiulla Rafi; Kamlesh Bhatt; Amanda McBride; William C Gause; Padmini Salgame
Journal:  J Exp Med       Date:  2011-08-08       Impact factor: 14.307

8.  Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG.

Authors:  Marie-Laure Bourigault; Noria Segueni; Stéphanie Rose; Nathalie Court; Rachel Vacher; Virginie Vasseur; François Erard; Marc Le Bert; Irene Garcia; Yoichiro Iwakura; Muazzam Jacobs; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  Immun Inflamm Dis       Date:  2013-10-30

9.  β-Glucan Induces Protective Trained Immunity against Mycobacterium tuberculosis Infection: A Key Role for IL-1.

Authors:  Simone J C F M Moorlag; Nargis Khan; Boris Novakovic; Eva Kaufmann; Trees Jansen; Reinout van Crevel; Maziar Divangahi; Mihai G Netea
Journal:  Cell Rep       Date:  2020-05-19       Impact factor: 9.423

10.  Anti-inflammatory Trained Immunity Mediated by Helminth Products Attenuates the Induction of T Cell-Mediated Autoimmune Disease.

Authors:  Shauna M Quinn; Kyle Cunningham; Mathilde Raverdeau; Robert J Walsh; Lucy Curham; Anna Malara; Kingston H G Mills
Journal:  Front Immunol       Date:  2019-05-21       Impact factor: 7.561

View more
  1 in total

1.  Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses.

Authors:  Morgane Mitermite; Dylan Gerard Ryan; Mimmi L E Lundahl; Sarah Case; Niamh C Williams; Ming Yang; Roisin I Lynch; Eimear Lagan; Filipa M Lebre; Aoife L Gorman; Bojan Stojkovic; Adrian P Bracken; Christian Frezza; Frederick J Sheedy; Eoin M Scanlan; Luke A J O'Neill; Stephen V Gordon; Ed C Lavelle
Journal:  Elife       Date:  2022-09-29       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.